{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:24:50Z","timestamp":1790796290838,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>\n                    Patients with end stage kidney disease (ESKD) and a previous acute myocardial infarction (AMI) have less access to KT. Data on ESKD patients with an AMI history who underwent first KT or dialysis between January 2007 and December 2018 were extracted from the Korean National Health Insurance Service. Patients who underwent KT (\n                    <jats:italic>n<\/jats:italic>\n                    = 423) were chronologically matched in a 1:3 ratio with those maintained on dialysis (\n                    <jats:italic>n<\/jats:italic>\n                    = 1,269) at the corresponding dates, based on time-conditional propensity scores. The 1, 5, and 10\u00a0years cumulative incidences for all-cause mortality were 12.6%, 39.1%, and 60.1% in the dialysis group and 3.1%, 7.2%, and 14.5% in the KT group. Adjusted hazard ratios (HRs) of KT versus dialysis were 0.17 (95% confidence interval [CI], 0.12\u20130.24;\n                    <jats:italic>p &amp;lt;<\/jats:italic>\n                    0.001) for mortality and 0.38 (95% CI, 0.23\u20130.51;\n                    <jats:italic>p &amp;lt;<\/jats:italic>\n                    0.001) for major adverse cardiovascular events (MACE). Of the MACE components, KT was most protective against cardiovascular death (HR, 0.23; 95% CI, 0.12\u20130.42;\n                    <jats:italic>p &amp;lt;<\/jats:italic>\n                    0.001). Protective effects of KT for all-cause mortality and MACE were consistent across various subgroups, including patients at higher risk (e.g., age &amp;gt;65\u00a0years, recent AMI [&amp;lt;6\u00a0months], congestive heart failure). KT is associated with lower all-cause mortality and MACE than maintenance dialysis patients with a prior AMI.\n                  <\/jats:p>","DOI":"10.3389\/ti.2023.11491","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:11:05Z","timestamp":1692835865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Survival Benefit of Kidney Transplantation in Patients With End-Stage Kidney Disease and Prior Acute Myocardial Infarction"],"prefix":"10.3389","volume":"36","author":[{"given":"Deok-Gie","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyuk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Ha","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Ryong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Won","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Geun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"B1","volume-title":"USRDS Annual Report, End Stage Renal Disease, Chapter 5. Mortality","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.ki.5002273","article-title":"Chronic Kidney Disease Management in the United Kingdom: NEOERICA Project Results","volume":"72","author":"Stevens","year":"2007","journal-title":"Kidney Int"},{"key":"B4","volume-title":"USRDS Annual Report, End Stage Renal Disease, Chapter 6. Transplantation","year":"2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","article-title":"Predicting Coronary Heart Disease After Kidney Transplantation: Patient Outcomes in Renal Transplantation (PORT) Study","volume":"10","author":"Israni","year":"2010","journal-title":"Am J Transpl"},{"key":"B6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1681\/asn.2004070580","article-title":"Incidence and Predictors of Myocardial Infarction After Kidney Transplantation","volume":"16","author":"Lentine","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/tp.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/ajt.13095","article-title":"Individual and Regional Factors of Access to the Renal Transplant Waiting List in France in a Cohort of Dialyzed Patients","volume":"15","author":"Bayat","year":"2015","journal-title":"Am J Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1600-6143.2011.03865.x","article-title":"Disparities in Provision of Transplant Information Affect Access to Kidney Transplantation","volume":"12","author":"Kucirka","year":"2012","journal-title":"Am J Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/nep.13484","article-title":"Access to Waitlisting for Deceased Donor Kidney Transplantation in Australia","volume":"24","author":"Sypek","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"B11","volume-title":"USRDS Annual Report, End Stage Renal Disdease, Chapter 8. Cardiovascular Disease in Patients With ESRD","year":"2020"},{"key":"B12","volume-title":"USRDS Annual Report, Chronic Kidney Disease, Chapter 4. Cardiovascular Disease in Patients With CKD","year":"2020"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1097\/tp.0000000000003070","article-title":"Renal Transplantation in Patients Older Than 60 Years With High Comorbidity. Is There a Survival Benefit? A Multicenter Study in Argentina","volume":"104","author":"Fragale","year":"2020","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-020-0410-z","article-title":"Non-Cardiac Surgery in Patients With Coronary Artery Disease: Risk Evaluation and Periprocedural Management","volume":"18","author":"Cao","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/SLA.0b013e3182125196","article-title":"Risk of Surgery Following Recent Myocardial Infarction","volume":"253","author":"Livhits","year":"2011","journal-title":"Ann Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","article-title":"Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/pds.5083","article-title":"Time-Related Biases in Pharmacoepidemiology","volume":"29","author":"Suissa","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B18","doi-asserted-by":"publisher","first-page":"m3342","DOI":"10.1136\/bmj.m3342","article-title":"Sodium Glucose Cotransporter 2 Inhibitors and Risk of Major Adverse Cardiovascular Events: Multi-Database Retrospective Cohort Study","volume":"370","author":"Filion","year":"2020","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/pds.4107","article-title":"Prevalent New-User Cohort Designs for Comparative Drug Effect Studies by Time-Conditional Propensity Scores","volume":"26","author":"Suissa","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1541-0420.2005.00356.x","article-title":"Propensity Score Matching With Time-Dependent Covariates","volume":"61","author":"Lu","year":"2005","journal-title":"Biometrics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance Diagnostics for Comparing the Distribution of Baseline Covariates Between Treatment Groups in Propensity-Score Matched Samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.amjcard.2015.01.529","article-title":"Trends in Management and Outcomes of ST-Elevation Myocardial Infarction in Patients With End-Stage Renal Disease in the United States","volume":"115","author":"Gupta","year":"2015","journal-title":"Am J Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ahj.2006.02.021","article-title":"The Use of Invasive Cardiac Procedures After Acute Myocardial Infarction in Long-Term Dialysis Patients","volume":"152","author":"Charytan","year":"2006","journal-title":"Am Heart J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e13195","DOI":"10.1111\/ctr.13195","article-title":"Racial Disparities in Kidney Transplant Waitlist Appearance in Chicago: Is it Race or Place?","volume":"32","author":"Peng","year":"2018","journal-title":"Clin Transpl"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1097\/tp.0000000000001002","article-title":"Survival Benefit in Renal Transplantation Despite High Comorbidity","volume":"100","author":"S\u00f8rensen","year":"2016","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival Benefit With Kidney Transplants From HLA-Incompatible Live Donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1053\/j.ajkd.2020.03.029","article-title":"Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival","volume":"76","author":"Massie","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1681\/asn.2005090984","article-title":"Acute Myocardial Infarction and Kidney Transplantation","volume":"17","author":"Kasiske","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ki.2014.335","article-title":"Cardiovascular Risk Assessment in Kidney Transplantation","volume":"87","author":"Hart","year":"2015","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation: The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation: The Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of Coronary Disease in Patients With Advanced Kidney Disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jacc.2018.05.057","article-title":"Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial","volume":"72","author":"Giustino","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/cir.0000000000000404","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.2215\/cjn.08680910","article-title":"Cardiac Survival After Pre-Emptive Coronary Angiography in Transplant Patients and Those Awaiting Transplantation","volume":"6","author":"Kumar","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive Heart Failure in Dialysis Patients: Prevalence, Incidence, Prognosis and Risk Factors","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2023.11491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:11:11Z","timestamp":1692835871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2023.11491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":38,"alternative-id":["10.3389\/ti.2023.11491"],"URL":"https:\/\/doi.org\/10.3389\/ti.2023.11491","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"article-number":"11491"}}